3. James Flanigan's article "Biotech Tries to Shrug off Setbacks," from the New York Times and found here: http://www.nytimes.com/2009/09/17/business/smallbusiness/17edge.html?_r=1 outlines the difficulties that biotech firms have had recently with Continue Reading...
Response 2: For the same reasons that smaller biotechnology carry more risk with each product, they are also more dependent on the profits from that product. By refraining from licensing until the drugs has made it through pre-clinical and phase o Continue Reading...
As to Latin America and the Caribbean, those nations receive 27% of the committed portfolio for both IFC and MIGA; Latin American and the Caribbean have 8.6% of their populations living under $1 a day. The reason that those two regions are given suc Continue Reading...
Managing All Stakeholders in the Context of a Merger Process Review of the Relevant Literature Types of Mergers Identifying All Stakeholders in a Given Business Strategic Market Factors Driving Merger Activity Selection Process for Merger Candi Continue Reading...
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while compe Continue Reading...
To some, that suggests that college is a more viable alternative for many of those who would otherwise have sought jobs in the manufacturing sector previously. However, there are at least two reasons that such a conclusion may be invalid. First, wh Continue Reading...
